Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study

1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. [cited 2023 Feb 28]. Available at: https://gco.iarc.fr/today FerlayJ ErvikM LamF ColombetM MeryL PiñerosM Global Cancer Observatory: Cancer Today Lyon, France International Agency for Research on Cancer 2020 [cited 2023 Feb 28]. Available at: https://gco.iarc.fr/today Search in Google Scholar

2. ECIS - European Cancer Information System. © European Union. 2023. [cited 2023 Feb 28]. Available at: https://ecis.jrc.ec.europa.eu ECIS - European Cancer Information System © European Union. 2023 [cited 2023 Feb 28]. Available at: https://ecis.jrc.ec.europa.eu Search in Google Scholar

3. Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47–55. doi: 10.1515/raon-2017-0008 ZadnikV Primic ZakeljM LokarK JarmK IvanusU ZagarT. Cancer burden in Slovenia with the time trends analysis Radiol Oncol 2017 51 47 55 10.1515/raon-2017-0008 Open DOISearch in Google Scholar

4. Statistical Office of the Republic of Slovenia. [cited 2023 Feb 12]. Available at: www.stat.si Statistical Office of the Republic of Slovenia [cited 2023 Feb 12]. Available at: www.stat.si Search in Google Scholar

5. Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention and screening. Prog Mol Biol Transl Sci 2017; 151: 1–32. doi: 10.1016/bs.pmbts.2017.07.002 WintersS MartinC MurphyD ShokarNK. Breast cancer epidemiology, prevention and screening Prog Mol Biol Transl Sci 2017 151 1 32 10.1016/bs.pmbts.2017.07.002 Open DOISearch in Google Scholar

6. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, Widschwendter M, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 2020; 17: 687–705. doi: 10.1038/s41571-020-0388-9 PashayanN AntoniouAC IvanusU EssermanLJ EastonDF WidschwendterM Personalized early detection and prevention of breast cancer: ENVISION consensus statement Nat Rev Clin Oncol 2020 17 687 705 10.1038/s41571-020-0388-9 Open DOISearch in Google Scholar

7. World Health Organization, International Agency for Research on Cancer. IARC handbooks of cancer prevention. Volume 15. Breast Cancer Screening. Lyon: IARC; 2016. World Health Organization, International Agency for Research on Cancer IARC handbooks of cancer prevention 15 Breast Cancer Screening Lyon IARC 2016 Search in Google Scholar

8. European Commission Initiative on Breast Cancer; 2023. [cited 2023 May 2]. Available at: https://healthcare-quality.jrc.ec.europa.eu/ecibc European Commission Initiative on Breast Cancer 2023 [cited 2023 May 2]. Available at: https://healthcare-quality.jrc.ec.europa.eu/ecibc Search in Google Scholar

9. Council Recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. 2022/0290(NLE). Brussels: Council of the European Union; 2022. [cited 2023 May 2]. Available at: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548 Council Recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. 2022/0290(NLE) Brussels Council of the European Union 2022 [cited 2023 May 2]. Available at: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548 Search in Google Scholar

10. Canelo-Aybar C, Ferreira DS, Ballesteros M, Posso M, Montero N, Sola I, et al. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer. J Med Screen 2021; 28: 389–404. doi: 10.1177/0969141321993866 Canelo-AybarC FerreiraDS BallesterosM PossoM MonteroN SolaI Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer J Med Screen 2021 28 389 404 10.1177/0969141321993866 Open DOISearch in Google Scholar

11. Román M, Sala M, Domingo L, Posso M, Louro J, Castells X. Personalized breast cancer screening strategies: a systematic review and quality assessment. PLoS One 2019; 14: e0226352. doi: 10.1371/journal.pone.0226352 RománM SalaM DomingoL PossoM LouroJ CastellsX. Personalized breast cancer screening strategies: a systematic review and quality assessment PLoS One 2019 14 e0226352 10.1371/journal.pone.0226352 Open DOISearch in Google Scholar

12. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999; 91: 1541–8. doi: 10.1093/jnci/91.18.1541 CostantinoJP GailMH PeeD AndersonS RedmondCK BenichouJ Validation studies for models projecting the risk of invasive and total breast cancer incidence J Natl Cancer Inst 1999 91 1541 8 10.1093/jnci/91.18.1541 Open DOISearch in Google Scholar

13. Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat 2019; 175: 519–23. doi: 10.1007/s10549-019-05167-2 TiceJA BissellMCS MigliorettiDL GardCC RauscherGH DabbousFM Validation of the breast cancer surveillance consortium model of breast cancer risk Breast Cancer Res Treat 2019 175 519 23 10.1007/s10549-019-05167-2 Open DOISearch in Google Scholar

14. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23: 1111–30. doi: 10.1002/sim.1668 TyrerJ DuffySW CuzickJ. A breast cancer prediction model incorporating familial and personal risk factors Stat Med 2004 23 1111 30 10.1002/sim.1668 Open DOISearch in Google Scholar

15. Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet 2022; 59: 1206–18. doi: 10.1136/jmedgenet-2022-108471 LeeA MavaddatN CunninghamA CarverT FicorellaL ArcherS Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence J Med Genet 2022 59 1206 18 10.1136/jmedgenet-2022-108471 Open DOISearch in Google Scholar

16. Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk Tool - a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol Biomarkers Prev 2021; 30: 469–73. doi: 10.1158/1055-9965.EPI-20-1319 CarverT HartleyS LeeA CunninghamAP ArcherS Babb de VilliersC CanRisk Tool - a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants Cancer Epidemiol Biomarkers Prev 2021 30 469 73 10.1158/1055-9965.EPI-20-1319 Open DOISearch in Google Scholar

17. Jarm K, Kadivec M, Šval C, Hertl K, Primic Žakelj M, Dean PB, et al. Quality assured implementation of the Slovenian breast cancer screening programme. PLoS One 2021; 16: e0258343. doi: org/10.1371/journal.pone.0258343 JarmK KadivecM ŠvalC HertlK Primic ŽakeljM DeanPB Quality assured implementation of the Slovenian breast cancer screening programme PLoS One 2021 16 e0258343 doi: org/10.1371/journal.pone.0258343 Search in Google Scholar

18. Blatnik A, Perhavec A, Gazić B, Vidergar-Kralj B, Matos E, Ratoša I, et al. [Recommendations for diagnosis and treatment of patients with breast cancer 2021]. [Slovenian]. Digital repository of Slovenian research organizations. Institute of Oncology Ljubljana. ISBN 978-961-7029-42-0. [cited 2023 Jan 21]. Available at: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=14846 BlatnikA PerhavecA GazićB Vidergar-KraljB MatosE RatošaI [Recommendations for diagnosis and treatment of patients with breast cancer 2021]. [Slovenian] Digital repository of Slovenian research organizations. Institute of Oncology Ljubljana ISBN 978-961-7029-42-0. [cited 2023 Jan 21]. Available at: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=14846 Search in Google Scholar

19. Zadnik V, Krajc M. [Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population]. [Slovenian]. Onkologija 2018; 22: 6–10. doi: 10.25670/oi2018-016on ZadnikV KrajcM. [Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population]. [Slovenian] Onkologija 2018 22 6 10 10.25670/oi2018-016on Open DOISearch in Google Scholar

20. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, et al, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition. Luxembourg: European Commission. Office for Official Publications of the European Communities; 2006. PerryN BroedersM de WolfC TörnbergS HollandR von KarsaL editors. European guidelines for quality assurance in breast cancer screening and diagnosis Fourth edition Luxembourg European Commission. Office for Official Publications of the European Communities 2006 Search in Google Scholar

21. Krajc M, Blatnik A, Kerševan T, Hotujec S. [Clinical pathway for patients’ care at the Department of clinical cancer genetics]. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana. [cited: 2023 May 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/klinicne_poti/Klinicna_pot_obravnave_pacienta_v_Ambulanti_za_onkolosko_genetsko_svetovanje_in_testiranje_2020.pdf KrajcM BlatnikA KerševanT HotujecS. [Clinical pathway for patients’ care at the Department of clinical cancer genetics]. [Slovenian] Ljubljana Institute of Oncology Ljubljana [cited: 2023 May 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/klinicne_poti/Klinicna_pot_obravnave_pacienta_v_Ambulanti_za_onkolosko_genetsko_svetovanje_in_testiranje_2020.pdf Search in Google Scholar

22. Sickles EA, D’Orsi CJ, Bassett LW. ACR BI-RADS^® mammography. In: ACR BI-RADS^® Atlas. Breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013. SicklesEA D’OrsiCJ BassettLW ACR BI-RADS^® mammography In: ACR BI-RADS^® Atlas. Breast imaging reporting and data system Reston, VA American College of Radiology 2013 Search in Google Scholar

23. World Health Organization. Menopause. [cited 2023 June 21]. Available at: https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women%20experience%20menopause%20between,changes%20in%20the%20menstrual%20cycle World Health Organization Menopause [cited 2023 June 21]. Available at: https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women%20experience%20menopause%20between,changes%20in%20the%20menstrual%20cycle Search in Google Scholar

24. Brentnall AR, Cuzick J. Risk models for breast cancer and their validation. Stat Sci 2020; 35: 14–30. doi: 10.1214/19-STS729 BrentnallAR CuzickJ Risk models for breast cancer and their validation Stat Sci 2020 35 14 30 10.1214/19-STS729 Open DOISearch in Google Scholar

25. Krajc M, Evans GD, Blatnik A, Lokar K, Žagar T, Tomšič S, et al. Screening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines - pilot study. Zdr Varst 2020; 18: 211–18. doi: 10.2478/sjph-2020-0027 KrajcM EvansGD BlatnikA LokarK ŽagarT TomšičS Screening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines - pilot study Zdr Varst 2020 18 211 18 10.2478/sjph-2020-0027 Open DOISearch in Google Scholar

26. IBIS breast cancer evaluation tool. [cited: 2023 April 10]. Available at: https://ems-trials.org/riskevaluator/ IBIS breast cancer evaluation tool [cited: 2023 April 10]. Available at: https://ems-trials.org/riskevaluator/ Search in Google Scholar

27. Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, et al. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Southampton, UK: NIHR Journals Library; 2016. doi: 10.3310/pgfar04110 EvansDG AstleyS StavrinosP HarknessE DonnellyLS DaweS Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study Southampton, UK NIHR Journals Library 2016 10.3310/pgfar04110 Open DOISearch in Google Scholar

28. Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Rossi PG, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial. BMC Cancer 2022; 22: 507. doi: 10.1186/s12885-022-09484-6 RouxA CholertonR SicsicJ MoumjidN FrenchDP RossiPG Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial BMC Cancer 2022 22 507 10.1186/s12885-022-09484-6 Open DOISearch in Google Scholar

29. Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, et al. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer 2016; 114: 1045–52. doi: 10.1038/bjc.2016.56 EvansDG DonnellyLS HarknessEF AstleySM StavrinosP DaweS Breast cancer risk feedback to women in the UK NHS breast screening population Br J Cancer 2016 114 1045 52 10.1038/bjc.2016.56 Open DOISearch in Google Scholar

30. Laza-Vásquez C, Martínez-Alonso M, Forné-Izquierdo C, Vilaplana-Mayoral J, Cruz-Esteve I, Sánchez-López I, et al. DECIDO Group. Feasibility and acceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial. Int J Environ Res Public Health 2022; 19: 10426. doi: 10.3390/ijerph191610426 Laza-VásquezC Martínez-AlonsoM Forné-IzquierdoC Vilaplana-MayoralJ Cruz-EsteveI Sánchez-LópezI DECIDO Group Feasibility and acceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial Int J Environ Res Public Health 2022 19 10426 10.3390/ijerph191610426 Open DOISearch in Google Scholar

31. Simonović S, Zadnik V, Hafner A. [Pilot testing of individual breast cancer risk tool at Breast centre Kranj]. [Slovenian]. Graduation thesis. Ljubljana: University of Ljubljana; 2017. [cited: 2023 March 20]. Available at: https://plus.cobiss.net/cobiss/si/sl/bib/2883451 SimonovićS ZadnikV HafnerA [Pilot testing of individual breast cancer risk tool at Breast centre Kranj]. [Slovenian] Graduation thesis. Ljubljana University of Ljubljana 2017 [cited: 2023 March 20]. Available at: https://plus.cobiss.net/cobiss/si/sl/bib/2883451 Search in Google Scholar

32. Oblak T, Zadnik V, Krajc M, Lokar K, Zgajnar J. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40–49 years - could it be better? Radiol Oncol 2020; 54: 335–40. doi: 10.2478/raon-2020-0040 OblakT ZadnikV KrajcM LokarK ZgajnarJ Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40–49 years - could it be better? Radiol Oncol 2020 54 335 40 10.2478/raon-2020-0040 Open DOISearch in Google Scholar

33. University Hospital of South Manchester. Genesis breast cancer prevention centre. Research overview 2014/15. Manchester: NHS Foundation trust; 2015. [cited: 2023 May 1]. Available at: http://www.breastcentre.manchester.ac.uk/Portals/12/Documents/Genesis%20Research%20Overview%202015.pdf University Hospital of South Manchester Genesis breast cancer prevention centre. Research overview 2014/15 Manchester NHS Foundation trust 2015 [cited: 2023 May 1]. Available at: http://www.breastcentre.manchester.ac.uk/Portals/12/Documents/Genesis%20Research%20Overview%202015.pdf Search in Google Scholar

34. Esserman LJ; WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 2017; 3: 34. doi: 10.1038/s41523-017-0035-5 EssermanLJ WISDOM Study and Athena Investigators The WISDOM Study: breaking the deadlock in the breast cancer screening debate NPJ Breast Cancer 2017 3 34 10.1038/s41523-017-0035-5 Open DOISearch in Google Scholar

35. My personal breast screening (MyPeBS). US National Library of Medicine. ClinicalTrials.gov ID NCT03672331. [cited: 2023 March 22]. Available at: https://clinicaltrials.gov/ct2/show/record/NCT03672331 My personal breast screening (MyPeBS) US National Library of Medicine ClinicalTrials.gov ID NCT03672331 [cited: 2023 March 22]. Available at: https://clinicaltrials.gov/ct2/show/record/NCT03672331 Search in Google Scholar

36. National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG164. NICE; 2013. [cited: 2023 March 1]. Available at: https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancer National Institute for Health and Care Excellence Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG164 NICE 2013 [cited: 2023 March 1]. Available at: https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancer Search in Google Scholar

37. Augustinsson A, Ellberg C, Kristoffersson U, Borg Å, Olsson H. Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer. Acta Oncol 2018; 57: 595–603. doi: 10.1080/0284186X.2017.1404635 AugustinssonA EllbergC KristofferssonU BorgÅ OlssonH Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer Acta Oncol 2018 57 595 603 10.1080/0284186X.2017.1404635 Open DOISearch in Google Scholar

38. National Institute of Public Health. Data portal. [cited 2023 June 20]. Available at: https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal/?rxid=9e76cdb9-ec30-4a1a-a1c4-9fce467492a8 National Institute of Public Health Data portal [cited 2023 June 20]. Available at: https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal/?rxid=9e76cdb9-ec30-4a1a-a1c4-9fce467492a8 Search in Google Scholar

39. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227–36. doi: 10.1056/NEJMoa062790 BoydNF GuoH MartinLJ SunL StoneJ FishellE Mammographic density and the risk and detection of breast cancer N Engl J Med 2007 356 227 36 10.1056/NEJMoa062790 Open DOISearch in Google Scholar

40. Checka CM Chun JE, Freya SR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR 2012; 198: 292–5. doi: 10.2214/AJR.10.6049 CheckaCM ChunJE FreyaSR LeeJ TothH The relationship of mammographic density and age: implications for breast cancer screening AJR 2012 198 292 5 10.2214/AJR.10.6049 Open DOISearch in Google Scholar

41. Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2016; 106: 255. doi: 10.1093/jnci/dju255 SpragueBL GangnonRE BurtV Trentham-DietzA HamptonJM WellmanRD Prevalence of mammographically dense breasts in the United States J Natl Cancer Inst 2016 106 255 10.1093/jnci/dju255 Open DOISearch in Google Scholar

42. Portnow LH, Georgian-Smith D, Haider I, Barrios M, Camden P, Bay CP, et al. Persistent inter-observer variability of breast density assessment using BI-RADS^® 5th edition guidelines. Clinical Imaging 2022; 83: 21–7. doi: 10.1016/j.clinimag.2021.11.034 PortnowLH Georgian-SmithD HaiderI BarriosM CamdenP BayCP Persistent inter-observer variability of breast density assessment using BI-RADS^® 5th edition guidelines Clinical Imaging 2022 83 21 7 10.1016/j.clinimag.2021.11.034 Open DOISearch in Google Scholar

43. Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res 2015; 17: 147. doi: 10.1186/s13058-015-0653-5 BrentnallAR HarknessEF AstleySM DonnellyLS StavrinosP SampsonS Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort Breast Cancer Res 2015 17 147 10.1186/s13058-015-0653-5 Open DOISearch in Google Scholar

44. A short guide to cancer screening: increase effectiveness, maximize benefits and minimize harm. World Health Organization. Regional Office for Europe; 2022. [cited: 2023 May 1]. Available at: https://apps.who.int/iris/handle/10665/351396 A short guide to cancer screening: increase effectiveness, maximize benefits and minimize harm World Health Organization. Regional Office for Europe 2022 [cited: 2023 May 1]. Available at: https://apps.who.int/iris/handle/10665/351396 Search in Google Scholar

45. Di Stefano F, Camussi E, Casnati G, Garena F, Ceresa M, Castagno R, et al. Communication of breast cancer risk and a personalized screening protocol: experience within the MyPeBS Study. [abstract]. Code: ICS18011-74. International Cancer Screening Network conference. Turin; 2023. Di StefanoF CamussiE CasnatiG GarenaF CeresaM CastagnoR Communication of breast cancer risk and a personalized screening protocol: experience within the MyPeBS Study. [abstract]. Code: ICS18011-74 International Cancer Screening Network conference Turin 2023 Search in Google Scholar

46. Kurir Borovčić M, Jarm K, Kutnar V, Škrbec V, Torkar K, Šval C, et al. Programme DORA yearly report of 2021. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana; 2022. [cited 2023 April 20]. Available at: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_Letno_porocilo_2021_WEB_apr_2022.pdf Kurir BorovčićM JarmK KutnarV ŠkrbecV TorkarK ŠvalC Programme DORA yearly report of 2021. [Slovenian] Ljubljana Institute of Oncology Ljubljana 2022 [cited 2023 April 20]. Available at: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_Letno_porocilo_2021_WEB_apr_2022.pdf Search in Google Scholar